Japanese researchers are soon embarking on human clinical trials for a medicine that will help regrow teeth.
Related Posts
Cipla Stock: Cipla is banking on US growth and strong India business. But are the positives priced in its stock?
Cipla has become one of the favourite large-cap stocks of investors of late. Since the Covid-19 outbreak in March 2020,…
As Novo Nordisk scales back, Eris and Biocon Biologics hit the sweet spot in India’s insulin market
“It is a small emergency,” says Amit Bakshi, chairman of Ahmedabad-based drugmaker Eris Lifesciences. He points to the recent decision…
Affordability is critical when it comes to patient care: GE HealthCare’s Sarawate
Chaitanya Sarawate, president and CEO of GE HealthCare South Asia and managing director of Wipro GE Healthcare; image credit: company.…